Bioatla Inc (BCAB)

Currency in USD
4.270
+0.060(+1.43%)
Closed·
4.300+0.030(+0.70%)
·

BCAB Earnings

Latest Release
Mar 31, 2026
EPS / Forecast
-0.16 / -0.22
Revenue / Forecast
2M / --
EPS Revisions
Last 90 days
Release Date
Period End
EPS
/Forecast
Revenue
/Forecast
EPS Surprise %
Revenue Surprise %
Reaction
03/2026--/-0.200--/0.000----Free Sign Up
12/2025-0.160/-0.2202.00M/0.000+27.27%--Free Sign Up
09/2025-0.270/-0.2700.000/0.0000%--Free Sign Up
06/2025-0.320/-0.260--/0.000-23.08%--Free Sign Up
03/2025-0.260/-0.390--/0.000+33.33%--Free Sign Up
12/2024-0.300/-0.3850.000/0.000+22.08%--Free Sign Up
09/2024-0.220/-0.41011.00M/0.000+46.34%--Free Sign Up
06/2024-0.440/-0.4500.000/0.000+2.22%--Free Sign Up
03/2024-0.480/-0.5400.000/0.000+11.11%--Free Sign Up
12/2023-0.560/-0.5600.000/3.00M0%-100%Free Sign Up

All numbers in USD

Bioatla Inc Earnings Call Summary for Q3/2025

  • Bioatla reported Q3 2025 EPS of -$0.27, meeting forecasts, but stock fell 4.09% to $0.67 amid investor concerns over increased net losses of $15.8M and low cash reserves of $8.3M.
  • Despite cost management efforts reducing R&D and G&A expenses, the company's net loss increased from $10.6M in Q3 2024, raising questions about financial sustainability.
  • Bioatla achieved FDA alignment for a phase 3 trial in OPSCC, with CEO Jay Short announcing plans to begin enrollment early next year and key clinical readouts expected in H1 2026.
  • Management plans to finalize a strategic transaction by year-end, focusing on prioritized programs while addressing the company's precarious cash position.
Last Updated: 11/14/2025, 06:24 AM
Read Full Transcript

FAQ

What Is Bioatla's Earnings Per Share (TTM)?

The Bioatla EPS (TTM) is -50.662.

When Is The Next Bioatla Earnings Date?

Bioatla will release its next earnings report on May 13, 2026.

What Is Bioatla’s Revenue Forecasts For Upcoming Quarters?

Bioatla’s revenue forecast is 0.00.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.